Abstract
Dupuytren's contracture is a world-wide disorder with established risk factors: heredity, age, male sex, diabetes mellitus, alcohol and tobacco consumption. Familial transmission of the disease is autosomal dominant with variable penetrance. Pathogenesis of Dupuytren's disease remains partially unknown. Treatment aims at reducing flexion contracture of the fingers and disability, but does not prevent recurrence. Digital deformity, hand disability and recurrence are outcome criteria of key importance in Dupuytren's disease. Unité Rhumatologique des Affections de la Main (URAM) scale is a tool that has recently been developed and validated to assess Dupuytren's disease related disability. Treatment modalities of Dupuytren's disease include percutaneous needle aponeurotomy, injectable collagenase, and surgical aponeurectomy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
